Insurance Coverage of Biosimilars: Prior Authorization and Tier Placement Strategies
Biosimilars offer major cost savings over biologics, but insurance coverage often blocks access through prior authorization and identical tier placement. Learn why these barriers persist and how they impact patient care in 2025.
View more